Hematological profile of pulmonary tuberculosis patients before and after 1 month of taking anti-TB drugs
Tuberculosis (TB) is an airborne infectious disease caused by Mycobacterium tuberculosis. Indonesia ranks third in the number of global TB cases. Studies in Indonesia show reduced levels of Hb, Ht, MCV, MCH, and leukocytosis in newly diagnosed and untreated TB patients, with 60% having anemia. The c...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | Indonesian |
| Published: |
Poltekkes Kemenkes Yogyakarta
2024-12-01
|
| Series: | Jurnal Teknologi Laboratorium |
| Subjects: | |
| Online Access: | https://teknolabjournal.com/index.php/Jtl/article/view/486 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841560769420853248 |
|---|---|
| author | Ririh Jatmi Wikandari Surati Siti Nuryani Sistoyono |
| author_facet | Ririh Jatmi Wikandari Surati Siti Nuryani Sistoyono |
| author_sort | Ririh Jatmi Wikandari |
| collection | DOAJ |
| description | Tuberculosis (TB) is an airborne infectious disease caused by Mycobacterium tuberculosis. Indonesia ranks third in the number of global TB cases. Studies in Indonesia show reduced levels of Hb, Ht, MCV, MCH, and leukocytosis in newly diagnosed and untreated TB patients, with 60% having anemia. The combined use of hematologic markers to assess inflammatory response before and after treatment still needs further investigation.This study was conducted in several Puskesmas in Semarang to determine the hematological profile of tuberculosis patients before and after 1 month of treatment. This study used a quasi-experimental design with one-group pre-test and post-test methods. The study population included all TB patients in the third area of the Puskesmas. Non-probability sampling technique with quota sampling is used to select a sample, consisting of newly diagnosed TB patients (aged 20-60 years, both male and female, and not cases of retreatment). A total of 30 samples were taken (10 from each Puskesmas). Analysis of blood samples is performed using the automated hematology device Sysmex (KX21-N). Data were analyzed using SPSS Version 25 with descriptive statistics and paired t-test was used to compare hematologic profiles before and after treatment. The results showed that anemia often occurred in tuberculosis patients and the number of patients who experienced anemia after treatment decreased from 16 patients to 13 patients. The study also found significant changes in white blood cell (p = 0.004) and platelet (p = 0.005) counts in tuberculosis patients before and after treatment. The increase in white blood cell count after treatment shows clinical improvement, while the decrease in platelets may be due to the action of anti-tuberculosis drugs. Normocytic normochromic anemia is the most common form of anemia in tuberculosis patients before treatment, while microcytic hypochromic anemia is more common after 1 month of treatment. |
| format | Article |
| id | doaj-art-48c5f5dcd4b04aec9eef24d567be4487 |
| institution | Kabale University |
| issn | 2338-5634 2580-0191 |
| language | Indonesian |
| publishDate | 2024-12-01 |
| publisher | Poltekkes Kemenkes Yogyakarta |
| record_format | Article |
| series | Jurnal Teknologi Laboratorium |
| spelling | doaj-art-48c5f5dcd4b04aec9eef24d567be44872025-01-03T15:40:12ZindPoltekkes Kemenkes YogyakartaJurnal Teknologi Laboratorium2338-56342580-01912024-12-0113213514410.29238/teknolabjournal.v13i2.486438Hematological profile of pulmonary tuberculosis patients before and after 1 month of taking anti-TB drugsRirih Jatmi Wikandari0Surati1Siti Nuryani2Sistoyono3Department of Health Analysis, Polytechnic Ministry of Health, Semarang, IndonesiaDepartment of Health Analysis, Polytechnic Ministry of Health, Semarang, IndonesiaDepartment of Medical Laboratory Technology, Polytechnic Ministry of Health, Yogyakarta, IndonesiaDepartment of Medical Laboratory Technology, Polytechnic Ministry of Health, Yogyakarta, IndonesiaTuberculosis (TB) is an airborne infectious disease caused by Mycobacterium tuberculosis. Indonesia ranks third in the number of global TB cases. Studies in Indonesia show reduced levels of Hb, Ht, MCV, MCH, and leukocytosis in newly diagnosed and untreated TB patients, with 60% having anemia. The combined use of hematologic markers to assess inflammatory response before and after treatment still needs further investigation.This study was conducted in several Puskesmas in Semarang to determine the hematological profile of tuberculosis patients before and after 1 month of treatment. This study used a quasi-experimental design with one-group pre-test and post-test methods. The study population included all TB patients in the third area of the Puskesmas. Non-probability sampling technique with quota sampling is used to select a sample, consisting of newly diagnosed TB patients (aged 20-60 years, both male and female, and not cases of retreatment). A total of 30 samples were taken (10 from each Puskesmas). Analysis of blood samples is performed using the automated hematology device Sysmex (KX21-N). Data were analyzed using SPSS Version 25 with descriptive statistics and paired t-test was used to compare hematologic profiles before and after treatment. The results showed that anemia often occurred in tuberculosis patients and the number of patients who experienced anemia after treatment decreased from 16 patients to 13 patients. The study also found significant changes in white blood cell (p = 0.004) and platelet (p = 0.005) counts in tuberculosis patients before and after treatment. The increase in white blood cell count after treatment shows clinical improvement, while the decrease in platelets may be due to the action of anti-tuberculosis drugs. Normocytic normochromic anemia is the most common form of anemia in tuberculosis patients before treatment, while microcytic hypochromic anemia is more common after 1 month of treatment.https://teknolabjournal.com/index.php/Jtl/article/view/486hematological; tuberculosis; anti tuberculosis drugs; intensive phase; anemia. |
| spellingShingle | Ririh Jatmi Wikandari Surati Siti Nuryani Sistoyono Hematological profile of pulmonary tuberculosis patients before and after 1 month of taking anti-TB drugs Jurnal Teknologi Laboratorium hematological; tuberculosis; anti tuberculosis drugs; intensive phase; anemia. |
| title | Hematological profile of pulmonary tuberculosis patients before and after 1 month of taking anti-TB drugs |
| title_full | Hematological profile of pulmonary tuberculosis patients before and after 1 month of taking anti-TB drugs |
| title_fullStr | Hematological profile of pulmonary tuberculosis patients before and after 1 month of taking anti-TB drugs |
| title_full_unstemmed | Hematological profile of pulmonary tuberculosis patients before and after 1 month of taking anti-TB drugs |
| title_short | Hematological profile of pulmonary tuberculosis patients before and after 1 month of taking anti-TB drugs |
| title_sort | hematological profile of pulmonary tuberculosis patients before and after 1 month of taking anti tb drugs |
| topic | hematological; tuberculosis; anti tuberculosis drugs; intensive phase; anemia. |
| url | https://teknolabjournal.com/index.php/Jtl/article/view/486 |
| work_keys_str_mv | AT ririhjatmiwikandari hematologicalprofileofpulmonarytuberculosispatientsbeforeandafter1monthoftakingantitbdrugs AT surati hematologicalprofileofpulmonarytuberculosispatientsbeforeandafter1monthoftakingantitbdrugs AT sitinuryani hematologicalprofileofpulmonarytuberculosispatientsbeforeandafter1monthoftakingantitbdrugs AT sistoyono hematologicalprofileofpulmonarytuberculosispatientsbeforeandafter1monthoftakingantitbdrugs |